| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |